Pang, H.-Y.,
Zhao, L.-Y,
Zhang, Z.-Q,
Galiullin, D.,
Chen, X.-L.,
Liu, K.,
Zhang, W.-H.,
Yang, K.,
Chen, X.-Z.,
Hu, J.-K. (2021) rate. The 3-year overall
survival (OS)
rate was not significant different in the LG and OG groups (66
Pang, HY,
Zhang, WH,
Liang, XW,
Zhang, ZQ,
Chen, XL,
Zhao, LY,
Liu, K,
Galiullin, D,
Yang, K,
Chen, XZ,
Hu, JK (2021) associated with overall
survival (OS) of GC patients. A nomogram based on prognostic score system was further
Sun, J.X.,
Sun, Z.Y.,
Gareev, I,
Yan, T,
Chen, X,
Ahmad, A,
Zhang, D.M.,
Zhao, B.X.,
Beylerli, O.,
Yang, G.,
Zhao, S.G. (2021) R-2276-5p in patients with glioma correlated with poorer
survival rates. RAB13 was identified